EA200600284A1 - Дооперационное лечение послеоперационной боли - Google Patents

Дооперационное лечение послеоперационной боли

Info

Publication number
EA200600284A1
EA200600284A1 EA200600284A EA200600284A EA200600284A1 EA 200600284 A1 EA200600284 A1 EA 200600284A1 EA 200600284 A EA200600284 A EA 200600284A EA 200600284 A EA200600284 A EA 200600284A EA 200600284 A1 EA200600284 A1 EA 200600284A1
Authority
EA
Eurasian Patent Office
Prior art keywords
postoperative pain
opted
treatment
surgery
dosage form
Prior art date
Application number
EA200600284A
Other languages
English (en)
Other versions
EA009213B1 (ru
Inventor
Брюс Е. Рейденберг
Дэниел А. Спайкер
Original Assignee
Еуро-Селтик С. А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Еуро-Селтик С. А. filed Critical Еуро-Селтик С. А.
Publication of EA200600284A1 publication Critical patent/EA200600284A1/ru
Publication of EA009213B1 publication Critical patent/EA009213B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Предлагается способ лечения послеоперационной боли у пациента, подвергающегося операции. Способ основан на дооперационном введении содержащей бупренорфин трансдермальной дозированной формы. Дозированная форма может быть введена пациенту, например, за 1-4 дня до операции. Альтернативные варианты изобретения включают применение последующих трансдермальных дозированных форм для лечения послеоперационной боли.
EA200600284A 2003-07-25 2004-07-26 Способ лечения послеоперационной боли EA009213B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49036303P 2003-07-25 2003-07-25
PCT/US2004/024009 WO2005011578A2 (en) 2003-07-25 2004-07-26 Preoperative treatment of post operative pain

Publications (2)

Publication Number Publication Date
EA200600284A1 true EA200600284A1 (ru) 2006-06-30
EA009213B1 EA009213B1 (ru) 2007-12-28

Family

ID=34115386

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600284A EA009213B1 (ru) 2003-07-25 2004-07-26 Способ лечения послеоперационной боли

Country Status (28)

Country Link
US (3) US20080026042A1 (ru)
EP (1) EP1638492B1 (ru)
JP (1) JP5632573B2 (ru)
KR (4) KR20090031961A (ru)
CN (1) CN1829489B (ru)
AT (1) ATE382354T1 (ru)
AU (1) AU2004261181B2 (ru)
BR (1) BRPI0412924A (ru)
CA (1) CA2529983C (ru)
CY (1) CY1107352T1 (ru)
DE (1) DE602004011055T2 (ru)
DK (1) DK1638492T3 (ru)
EA (1) EA009213B1 (ru)
ES (1) ES2299871T3 (ru)
GE (1) GEP201606538B (ru)
HK (1) HK1087907A1 (ru)
HR (1) HRP20080146T3 (ru)
IL (1) IL173345A (ru)
IS (1) IS8186A (ru)
MA (1) MA28005A1 (ru)
MX (1) MXPA06000990A (ru)
NO (1) NO326636B1 (ru)
NZ (1) NZ594154A (ru)
PL (1) PL1638492T3 (ru)
PT (1) PT1638492E (ru)
UA (1) UA81689C2 (ru)
WO (1) WO2005011578A2 (ru)
ZA (1) ZA200510071B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE10361306A1 (de) * 2003-12-24 2005-07-28 Lts Lohmann Therapie-Systeme Ag Wundauflage und Wundschnellverband mit einem vasokonstriktorischen Inhaltsstoff, sowie Herstellungsverfahren hierfür
JP2011251944A (ja) * 2010-06-02 2011-12-15 Kansai Medical Univ 埋植用鎮痛製剤
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
PT2611445T (pt) 2010-09-03 2018-10-24 Zoetis Belgium S A Composições de buprenorfina de dose elevada e utilização como analgésico
RU2459640C2 (ru) * 2010-10-26 2012-08-27 Государственное учреждение здравоохранения "Воронежская областная клиническая больница № 1" Способ послеоперационного обезболивания больных, оперированных под спинальной анестезией
RU2487734C1 (ru) * 2011-11-17 2013-07-20 Анатолий Анатольевич Лаврентьев Способ послеоперационного обезболивания
RU178867U1 (ru) * 2016-05-04 2018-04-20 Общество с ограниченной ответственностью Научно-производственное предприятие "НОК" Вакуумная микроразмерная кристаллизационная ячейка
RU2649961C1 (ru) * 2017-02-28 2018-04-05 Федеральное государственное бюджетное научное учреждение "Томский национальный исследовательский медицинский центр Российской академии наук" (Томский НИМЦ) Способ обезболивания после проведения операции кесарева сечения у пациенток с избыточной массой тела

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4119713A (en) * 1977-02-09 1978-10-10 Sam Carosio Analgesic and anti-inflammatory composition
US4806341A (en) * 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
US5240711A (en) * 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
KR950005865B1 (ko) * 1990-04-23 1995-06-02 데이진 가부시끼가이샤 첩부제
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
SE9003665D0 (sv) * 1990-11-16 1990-11-16 Kabivitrum Ab Morphine prodrugs
JP2669951B2 (ja) * 1991-03-28 1997-10-29 雍憲 森本 麻薬性鎮痛剤を含有する経皮吸収組成物
US5613958A (en) * 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
CA2174803C (en) * 1996-04-23 2000-07-11 Jonathan P. Wong Use of liposome encapsulated ciprofloxacin as an immunotherapeutic drug
JPH1036265A (ja) * 1996-07-19 1998-02-10 Nitto Denko Corp ブプレノルフィン経皮吸収製剤
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US5942530A (en) * 1997-08-28 1999-08-24 Eli Lilly And Company Method for treating pain
KR100383252B1 (ko) * 1998-12-17 2003-07-16 주식회사 삼양사 부프레놀핀을함유하는경피투여조성물및이를포함하는패취
DE19901085C2 (de) * 1999-01-14 2003-12-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps
JP4659943B2 (ja) * 2000-02-25 2011-03-30 帝三製薬株式会社 塩酸ブプレノルフィン含有貼付剤
AU2001262683A1 (en) * 2000-06-02 2001-12-17 Teijin Limited Buprenorphine-containing patch
GB0026137D0 (en) * 2000-10-25 2000-12-13 Euro Celtique Sa Transdermal dosage form
US20020106407A1 (en) * 2000-12-11 2002-08-08 Dennis Coleman Method and apparatus for treating breakthrough pain
PT2113315E (pt) * 2001-04-23 2014-08-25 Euro Celtique Sa Sistema de eliminação para uma forma de dosagem transdérmica
DE60230138D1 (de) * 2001-05-01 2009-01-15 Euro Celtique Sa Vor missbrauch geschützte opioid-haltige transdermale systeme
JP4302991B2 (ja) * 2001-05-22 2009-07-29 ユーロ−セルティーク エス．エイ． 経皮性剤形を分配する容器及び装置
DK1572167T3 (da) * 2002-12-13 2008-10-13 Euro Celtique Sa Transdermal buprenophindoseringsbehandlingsplan for analgesi

Also Published As

Publication number Publication date
ES2299871T3 (es) 2008-06-01
EP1638492A4 (en) 2006-07-19
PT1638492E (pt) 2008-03-17
ZA200510071B (en) 2006-11-29
EA009213B1 (ru) 2007-12-28
PL1638492T3 (pl) 2008-06-30
HRP20080146T3 (en) 2008-04-30
KR20060054346A (ko) 2006-05-22
CA2529983A1 (en) 2005-02-10
DK1638492T3 (da) 2008-05-13
BRPI0412924A (pt) 2006-09-26
AU2004261181B2 (en) 2009-08-06
AU2004261181A1 (en) 2005-02-10
IL173345A (en) 2010-06-16
IL173345A0 (en) 2006-06-11
WO2005011578A2 (en) 2005-02-10
US20140221413A1 (en) 2014-08-07
DE602004011055D1 (de) 2008-02-14
JP2007500133A (ja) 2007-01-11
IS8186A (is) 2005-12-19
NO326636B1 (no) 2009-01-26
GEP201606538B (en) 2016-09-12
KR20090031961A (ko) 2009-03-30
MA28005A1 (fr) 2006-07-03
CY1107352T1 (el) 2012-12-19
KR20080011248A (ko) 2008-01-31
NO20060912L (no) 2006-04-21
JP5632573B2 (ja) 2014-11-26
NZ594154A (en) 2012-12-21
CN1829489B (zh) 2010-12-15
DE602004011055T2 (de) 2008-12-18
ATE382354T1 (de) 2008-01-15
EP1638492B1 (en) 2008-01-02
HK1087907A1 (en) 2006-10-27
US20110002975A1 (en) 2011-01-06
UA81689C2 (ru) 2008-01-25
CA2529983C (en) 2010-07-20
MXPA06000990A (es) 2006-04-11
KR20120128715A (ko) 2012-11-27
US20080026042A1 (en) 2008-01-31
WO2005011578A3 (en) 2005-09-09
CN1829489A (zh) 2006-09-06
EP1638492A2 (en) 2006-03-29

Similar Documents

Publication Publication Date Title
CY1107352T1 (el) Προεγχειρητικη θεραπευτικη αγωγη μετεγχειρητικου πονου
BRPI0406667A (pt) Método para o tratamento de câncer, e, formulação terapeuticamente aceitável de 2-dg
DE60222137D1 (de) Zuckerderivate von hydromorphon, dihydromorphin und dihydroisomorphin, zusammensetzungen davon und verwendung zur vorbeugung und behandlung von schmerzen
IS2630B (is) Meðferð á fráhvarfseinkennum
ATE423560T1 (de) Transdermale dosierungsform enthaltend einen wirkstoff und einen antagonisten in freier base und in salz form
EA200600820A1 (ru) Способы лечения, модификации и устранения боли с использованием 1-оксо-2-(2,6-диоксопиперидин-3-ил)-4-метилизоиндолина
DK1476141T3 (da) Manipulationssikrede anordninger til transdermal opioidadministration
WO2004039325A3 (en) Treatment of pain with jnk inhibitors
ATE394097T1 (de) Verfahren zur verabreichung von buprenorphin zur behandlung von depression
ATE414522T1 (de) Verfahren zur behandlung von akuter und durch übermässige beanspruchung verursachter zerrung und verstauchung mit hyaluronsäure
ATE310509T1 (de) Methode zur behandlung eines analgesiebedürftigen patienten
ATE487480T1 (de) Perhexilin zur behandlung von chronischer herzinsuffizienz
ATE330600T1 (de) Kombinationspräparat zur krebstherapie
WO2008088987B1 (en) Treatment of pain with naloxone
WO2008133952A3 (en) Transmucosal treatment with fentanyl in patients with mucositis

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): MD TJ

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG RU